Related references
Note: Only part of the references are listed.Effect of Phosphodiesterase Inhibition on Insulin Resistance in Obese Individuals
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or type 2 diabetes
R. E. van Genugten et al.
DIABETOLOGIA (2013)
Decreased Permeability Surface Area for Glucose in Obese Women with Postprandial Hyperglycemia: No Effect of Phosphodiesterase-5 (PDE-5) Inhibition
M. Sandqvist et al.
HORMONE AND METABOLIC RESEARCH (2013)
Reduced NO-cGMP Signaling Contributes to Vascular Inflammation and Insulin Resistance Induced by High-Fat Feeding
Norma O. Rizzo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes
P. -A. Jansson et al.
DIABETOLOGIA (2010)
Phosphodiesterase 5 Inhibition Improves β-Cell Function in Metabolic Syndrome
Kevin D. Hill et al.
DIABETES CARE (2009)
Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk
GMC Rosanoa et al.
EUROPEAN UROLOGY (2005)
Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin
MA Vincent et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)